Antenatal corticosteroid treatment for women with hypertensive disorders of pregnancy: A population-based study in Japan.

ABSTRACT: This study aimed to evaluate the current antenatal corticosteroid (ACS) treatment practices for hypertensive disorders of pregnancy (HDP) in Japan, by evaluating annual trends and identifying clinical disparities and factors influencing non-administration of ACS. This retrospective population-based study was conducted using the Japanese Perinatal Research Network Database from 2013 to 2022. We analyzed ACS administration rates over time, across facility types, and the timing of delivery. Factors influencing non-administration were identified using univariate and multivariate logistic regression analyses. ACS administration rates among patients with HDP nearly doubled over the past decade, reaching 64.0% in 2022. Approximately 70% of patients with HDP who received ACS delivered before 34 we

SUBMITTER: Ushida T 

PROVIDER: S-EPMC12223469 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature